Completed OBSERVATIONAL NCT01989624

PAncreatic Adenocarcinoma in Hospital (APACH)

Sponsor: Centre Hospitalier Departemental Vendee

Updated 10 times since 2017 Last updated: Mar 11, 2022 Started: Oct 18, 2013 Primary completion: Dec 4, 2015 Completion: Dec 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Pancreatic Adenocarcinoma and is currently completed. Centre Hospitalier Departemental Vendee leads this study, which shows 10 recorded versions since 2013 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

10 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Apr 2022 — Jul 2024 [monthly]

Completed
Apr 2021 — Apr 2022 [monthly]

Completed

Status: Unknown Status → Completed

▶ Show 5 earlier versions

Jan 2021 — Apr 2021 [monthly]

Unknown Status

Status: Active Not Recruiting → Unknown Status
Aug 2018 — Jan 2021 [monthly]

Active Not Recruiting
Jun 2018 — Aug 2018 [monthly]

Active Not Recruiting
Apr 2018 — Jun 2018 [monthly]

Active Not Recruiting

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Active Not Recruiting NA

First recorded

Oct 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Centre Hospitalier Departemental Vendee

Data source: Centre Hospitalier Departemental Vendee

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aix-en-Provence, France , Angoulême, France , Aubenas, France , Auch, France , Aulnay-sous-Bois, France , Avignon, France , Bagnols-sur-Cèze, France , Bayeux, France , Blois, France , Bourg-en-Bresse, France and 56 more locations